Vetanova

Vetanova ROE

Delisted

The Return on Equity (ROE) of Vetanova (VTNA) as of Nov 2, 2026 is -2,370.24 %. In the previous year, Return on Equity (ROE) was -600.00 % — a change of 295.04% (lower).

ROE

-2,370.24 %

YoY

295.04%

Last updated:

In 2021, Vetanova's return on equity (ROE) was -2,370.24 %, a 295.04% increase from the -600.00 % ROE in the previous year.

The Vetanova ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2014
66.67 USD
Jan 1, 2015
520.00 USD
Jan 1, 2019
0.00 USD
Jan 1, 2020
-600.00 USD
Jan 1, 2021
-2,370.24 USD
The Vetanova ROE history
YEARROEYoY
-2,370.24 %+295.04%
-600.00 %—
0.00-100.00%
520.00 %+680.00%
66.67 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Vetanova Stock analysis

What does Vetanova do? Vetanova Inc is a company that specializes in the production of veterinary medicines and has its roots in the animal health industry. It was founded in 2005 by a team of experienced veterinarians with the aim of improving the treatment of pets and livestock through the development of innovative products. Vetanova's business model is based on the manufacturing and marketing of veterinary medicines, as well as the sale of pet food and care products. The company's different divisions include both the development and production of prescription drugs and over-the-counter products, which are sold in specialty stores and online shops. Vetanova has specialized particularly in the development of medicines against infections, parasites, and inflammation. The company relies on a combination of traditional and modern manufacturing processes to bring high-quality products to the market. In addition to manufacturing medicines, Vetanova also offers a variety of products for the care and nutrition of pets. These include dietary supplements, pet care products, and specialized pet food tailored to their needs. As a company dedicated to the quality of its products and the health of animals, Vetanova works closely with veterinarians and breeders to ensure that its products meet high standards. In this regard, Vetanova also strives to intensify collaboration with scientific institutions to improve and further develop the effectiveness of its products. Animal welfare is also an important factor for Vetanova. The company advocates for the protection and well-being of animals and supports projects that help animals in need. In summary, Vetanova is a successful and renowned company that has specialized in the development and production of veterinary medicines since 2005. The company offers a wide range of products, including both prescription and over-the-counter products, targeting both pets and livestock. Vetanova is dedicated to the health of animals and focuses on collaborating with veterinarians and breeders to improve the effectiveness and quality of its products. Animal welfare and sustainability are other important aspects emphasized by Vetanova. Vetanova is one of the most popular companies on Eulerpool.

ROE Details

Decoding Vetanova's Return on Equity (ROE)

Vetanova's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Vetanova's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Vetanova's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Vetanova’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Vetanova stock

Return on Equity (ROE) of Vetanova is -2,370.24 % in 2021.

Return on Equity (ROE) of Vetanova changed from -600.00 % to -2,370.24 %, representing a 295.04% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Vetanova since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Vetanova with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Vetanova

All Key Metrics — Vetanova